GD3 Synthase Activators
GD3 Synthase is an enzyme integral to the biosynthetic pathway of gangliosides, specifically involved in the conversion of GM3 to GD3. This enzyme operates within the broader context of glycosphingolipid metabolism, playing a pivotal role in cell membrane composition and the regulation of cell signaling pathways. The functional activity of GD3 Synthase is crucial for the synthesis of complex gangliosides, which are implicated in various cellular processes, including proliferation, differentiation, and apoptosis. The expression and activity of GD3 Synthase are tightly regulated within cells, reflecting its significance in maintaining cellular homeostasis and responding to physiological changes. The enzyme's activity is influenced by the availability of its substrates and the cellular demand for GD3 gangliosides, which serve not only as components of the cell membrane but also as modulators of cell signaling cascades. The regulation of GD3 Synthase, therefore, is a reflection of the cell's metabolic state and its adaptive responses to external stimuli.
The activation of GD3 Synthase is intricately linked to cellular signaling mechanisms that respond to changes in the cell's internal and external environments. This activation can be influenced indirectly by various factors, including alterations in sphingolipid metabolism and the signaling pathways that govern cell growth, apoptosis, and stress responses. For instance, the enzyme can be activated by shifts in the levels of sphingosine-1-phosphate, a sphingolipid metabolite known to play a key role in the regulation of cell survival and apoptosis, through its action on specific receptors that trigger downstream signaling cascades. Additionally, the modulation of ceramide levels, a precursor in the synthesis of sphingolipids, can indirectly influence the activity of GD3 Synthase by altering the balance between cell survival and apoptosis signaling pathways.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate (S1P) activates S1P receptors, which can lead to the activation of downstream signaling pathways that influence cellular processes including the upregulation of enzymes involved in ganglioside biosynthesis, such as GD3 Synthase. | ||||||
C2 Ceramide | 3102-57-6 | sc-201375 sc-201375A | 5 mg 25 mg | $124.00 $460.00 | 12 | |
Ceramide can initiate a cascade of signaling events through its conversion to sphingosine and subsequently sphingosine-1-phosphate, indirectly promoting the activation of pathways that can enhance GD3 Synthase activity. | ||||||
Fumonisin B1 | 116355-83-0 | sc-201395 sc-201395A | 1 mg 5 mg | $200.00 $680.00 | 18 | |
Fumonisin B1 inhibits ceramide synthase, leading to an accumulation of sphingosine and sphinganine. This accumulation can shift the balance towards sphingosine-1-phosphate formation, indirectly supporting GD3 Synthase activation. | ||||||
D-erythro-Sphingosine | 123-78-4 | sc-3546 sc-3546A sc-3546B sc-3546C sc-3546D sc-3546E | 10 mg 25 mg 100 mg 1 g 5 g 10 g | $90.00 $194.00 $510.00 $2448.00 $9384.00 $15300.00 | 2 | |
D-Erythro-Sphinganine, a sphinganine analog, serves as a substrate for sphingosine kinases, potentially increasing sphingosine-1-phosphate levels and indirectly activating signaling pathways that could enhance GD3 Synthase activity. | ||||||
C-8 Ceramide | 74713-59-0 | sc-205233 sc-205233A sc-205233B | 1 mg 5 mg 25 mg | $19.00 $63.00 $228.00 | 1 | |
C8-Ceramide mimics natural ceramides in signaling pathways, potentially altering the balance towards sphingosine-1-phosphate production and indirectly activating signaling cascades that upregulate GD3 Synthase activity. | ||||||
Sphingomyelin | 85187-10-6 | sc-201381 sc-201381A | 100 mg 500 mg | $180.00 $560.00 | 3 | |
Sphingomyelin breakdown leads to ceramide production, indirectly influencing sphingosine and sphingosine-1-phosphate levels. This can activate signaling pathways that support GD3 Synthase activity enhancement. | ||||||
D-erythro-N,N-Dimethylsphingosine | 119567-63-4 | sc-201373 sc-201373A | 5 mg 25 mg | $81.00 $316.00 | 1 | |
N,N-Dimethylsphingosine inhibits sphingosine kinases, potentially leading to altered sphingolipid metabolism and indirect effects on signaling pathways that could promote GD3 Synthase activation through compensatory mechanisms. | ||||||
Phytosphingosine | 554-62-1 | sc-201385 sc-201385A | 5 mg 25 mg | $102.00 $427.00 | 4 | |
Phytosphingosine can be phosphorylated to phytosphingosine-1-phosphate, potentially influencing sphingolipid signaling pathways and indirectly activating mechanisms that could upregulate GD3 Synthase. | ||||||
Ceramide C6 | 124753-97-5 | sc-3527 sc-3527A | 5 mg 25 mg | $90.00 $337.00 | 42 | |
C6-Ceramide, a synthetic analog of natural ceramides, can modulate sphingolipid metabolism, potentially altering signaling pathways in a manner that indirectly supports the activation of GD3 Synthase. | ||||||
Safingol | 15639-50-6 | sc-204258 | 1 mg | $235.00 | 1 | |
Safingol, a sphinganine kinase inhibitor, may lead to altered sphingolipid dynamics and indirectly facilitate signaling pathways that activate GD3 Synthase by modulating the levels of sphingosine and its derivatives. | ||||||